CClinicalTrials.gg
CompletedNCT03434587Updated Feb 27, 2019

Syndactyly Versus Closed Reduction in 5th Metacarpal Neck Fracture

An interventional study of Syndactyly and Reduction and inmobilization in Metacarpal Fracture, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-27.

Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to compare the functional results of two different therapeutic approaches in patients that present with a 5th metacarpal neck fracture. Patients will be randomly assigned to be treated with either syndactyly or closed reduction plus inmovilization.

Read the detailed description

Syndactyly, although limiting the activity of the patient, allows a quick mobilization and recovery, as well as a better management in daily activities compared with immobilization with splint. In addition, follow-up of these fractures is difficult due to poor compliance, since patient profile is young people who give little relevance to their pathology in the hand.

The purpose of our study is to carry out a randomized clinical trial of good methodological quality to assess whether immobilization with syndactyly for 3 weeks does not imply loss of functionality or residual symptoms, avoiding rigidity, postinflammation arthritis or loss of grip strength, demonstrating that early mobilization of fractures of the fifth metacarpal provides clinically satisfactory results compared to prolonged immobilization provided that the volar fracture angle does not exceed 70 ° nor does it produce digital movement disruption.

02

Conditions studied

  • Metacarpal Fracture

Browse trials for

Keywords

  • fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men and Women ≥ 18 years old.
  • Admitted to the Emergency Department with fracture of 5th metacarpal neck, in acute phase (maximum 72 h of evolution) with a possibility of clinical and radiological follow-up of at least 6 months.
  • Willing to participate in the study and give their consent in writing.

Exclusion criteria

  • Patients younger than 18 years.
  • Patients presenting with more than 72 h of evolution
  • Patients with comminuted neck fractures.
  • Patients with angulation greater than 70 in the lateral-oblique plane
  • Patients with clinical-radiological disruption
  • Patients with previous fractures in the metacarpal.
  • Patients with open fracture grade II-III Gustilo.
  • Patients with bifocal fractures or fractures in another metacarpal-phalanx or carpal bones requiring different treatment.
  • Polytraumatized patients requiring further care that prevents them from adjusting to the therapeutic regimen specific to the protocol of isolated metacarpal fractures.
  • Patients with congenital anomalies on hand affect
  • Patients with a psychic disability (dementia-psychiatric illness or mental disorder) that prevents their collaboration in the follow-up
  • Patients with medical or surgical pathologies that at the discretion of the investigator do not allow their participation in the study.
  • Patients with inability to understand the nature and purpose of the study and / or to accept written participation in the study.
  • Unable to attend the pre-established clinical follow-up.
  • Do not wish to participate or give their consent in writing.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Syndactyly

    Syndactyly

    Procedure: Syndactyly

  • Active comparator
    Reduction and inmobilization

    Closed reduction and splint inmobilization

    Procedure: Reduction and inmobilization

Interventions

  • ProcedureSyndactyly

    Syndactyly

  • ProcedureReduction and inmobilization

    Closed reduction and inmobilization with splint

05

What researchers measure

Primary outcomes

  1. Disabilities of the Arm, Shoulder and Hand (DASH) score

    Comparison of DASH score at 9 weeks of emergency care in both treatment groups. Score range is from 0 to 100

    Time frame: 9 weeks

Secondary outcomes

  1. Disabilities of the Arm, Shoulder and Hand (DASH) score

    Comparison of DASH score at 3,6 weeks, 3 months and 1 year of emergency care in both treatment groups.

    Time frame: 3 weeks, 1 year

  2. Time to go back to job and sports

    Comparison of the time to incorporation into the work and sports activity between both groups.

    Time frame: 1 year

  3. Angulation,

    Comparison of angulation between both groups

    Time frame: 3 weeks, 9 weeks

  4. Range of mobility

    Comparison of range of mobility between both groups

    Time frame: 3 weeks, 9 weeks

  5. Grip strength

    Comparison of grip strength between both groups

    Time frame: 3 weeks, 9 weeks

  6. Visual Analogic Scale (VAS) for Pain score

    Comparison of VAS score

    Time frame: 3 weeks, 9 weeks, 1 year

  7. Complication rate

    Frequency of complications

    Time frame: 1 year

  8. Patient satisfaction (Modified Cooney Scale)

    Satisfaction with the assigned treatment and its result between groups, measured by the modified cooney scale that ranges from 0 to 100

    Time frame: 1 year

06

Study locations

1 site
  • Fundacion Jimenez Diaz
    Madrid, 28040, Spain
07

Registry details

Key details

Study ID
NCT03434587
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Sponsor
First posted
Feb 15, 2018
Start date
Aug 2016
Primary completion
Jan 31, 2019
Completion
Jan 31, 2019
Last update
Feb 27, 2019

Study contacts

Samuel Pajares, MD
principal investigator · IIS-FJD

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion